5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 46.60▲ | 46.42▲ | 46.43▲ | 44.55▲ | 44.24▲ |
MA10 | 46.57▲ | 46.25▲ | 46.30▲ | 44.39▲ | 40.41▲ |
MA20 | 46.42▲ | 46.35▲ | 45.40▲ | 43.46▲ | 39.68▲ |
MA50 | 46.28▲ | 44.65▲ | 44.43▲ | 39.51▲ | 41.98▲ |
MA100 | 46.24▲ | 44.39▲ | 44.75▲ | 39.35▲ | 38.82▲ |
MA200 | 45.53▲ | 44.43▲ | 41.62▲ | 39.72▲ | 31.17▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.023▲ | -0.051▼ | 0.084▲ | 0.022▲ | 1.136▲ |
RSI | 63.698▲ | 66.599▲ | 66.996▲ | 65.625▲ | 63.582▲ |
STOCH | 79.726 | 78.982 | 59.634 | 43.032 | 83.614▲ |
WILL %R | -18.033▲ | -8.527▲ | -17.974▲ | -10.317▲ | -3.933▲ |
CCI | 90.237 | 174.261▲ | 81.974 | 111.014▲ | 143.321▲ |
Monday, September 29, 2025 07:33 AM
Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted ...
|
Monday, September 29, 2025 06:11 AM
Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced the appointment of Alan Sandler, ...
|
Wednesday, September 24, 2025 03:15 AM
What began as a cautious ride earlier in the year has swelled into a full-blown bull market. The S&P 500 has climbed 14% in 2025, while the ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
30/09/25 | 45.91 | 46.805 | 45.49 | 46.70 | 1,615,010 |
29/09/25 | 44.05 | 47.22 | 44.05 | 46.07 | 3,795,755 |
26/09/25 | 42.79 | 44.02 | 42.7834 | 43.92 | 1,934,354 |
25/09/25 | 43.12 | 43.59 | 42.18 | 42.51 | 1,531,277 |
24/09/25 | 44.26 | 44.88 | 43.16 | 43.54 | 1,919,111 |
23/09/25 | 44.18 | 44.55 | 43.91 | 44.205 | 1,547,337 |
22/09/25 | 43.88 | 45.23 | 43.51 | 44.41 | 2,008,788 |
19/09/25 | 45.52 | 45.54 | 43.40 | 43.54 | 2,868,241 |
18/09/25 | 44.20 | 45.36 | 44.03 | 45.22 | 1,765,125 |
17/09/25 | 44.74 | 45.305 | 43.70 | 43.81 | 2,472,556 |
|
|
||||
|
|
||||
|
|